PMS of Spesolimab I.V. in GPP Patients With Acute Symptoms

NCT05670821 · clinicaltrials.gov ↗

COMPLETED

Status

52

Enrollment

INDUSTRY

Sponsor class

Conditions

Generalized Pustular Psoriasis

Interventions

DRUG: Spesolimab

Sponsor

Boehringer Ingelheim